FountainVest, Primavera invest $557m in China pharmacy chain
FountainVest Partners and Primavera Capital have paid $557 million for a 24.78% stake in Chinese pharmacy chain Laobaixing. It will provide a full exit for EQT Partners.
The two investors will each take approximately 12.4% shares via FountainVest China Capital Partners Fund III and Primavera Capital Fund III, according to a statement. EQT Partners became the second-largest...
More on Greater China
Latest News
Sequoia, ChrysCapital to exit India's Curatio
Sequoia Capital India and ChrysCapital Partners are set to exit Indian skincare brand Curatio, with Torrent Pharma agreeing to acquire 100% of the company for INR 20bn (USD 245m).
India's Molbio secures Temasek backing, becomes unicorn
India’s Molbio Diagnostics, a medical equipment maker best known for its COVID-19 testing systems, has raised a USD 85m round featuring Temasek Holdings at an enterprise valuation of USD 1.6bn.
China silicon supplier Lihao gets $305m Series B
Lihao Semiconductor, a China-based supplier of silicon materials used in solar panels, has raised CNY 2.2bn (USD 305m) in Series B funding from an investor group featuring Oceanpine Capital, V Fund, and Harvest Capital.
OTPP opens Mumbai office
Ontario Teachers’ Pension Plan (OTPP) has opened an office in Mumbai, adding India to an Asian footprint that currently includes bases in Hong Kong and Singapore.